SLNO FY 2018 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

-$2M

Operating Income

-$14M

Net Income

-$13M

EPS (Diluted)

$-9.54

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$988,000

Balance Sheet

Total Assets

$43M

Total Liabilities

$13M

Stockholders' Equity

$30M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$1.6B	+100.0%
Gross Profit	-$2M	-$1.6B	+99.9%
Operating Income	-$14M	-$12M	-17.5%
Net Income	-$13M	-$16M	+14.9%